中国启动了到2030年将乙型儿童肝炎降低至0.2%的计划,通过全面检测、疫苗接种和技术驱动的护理。 China launches plan to cut child hepatitis B to 0.2% by 2030 with universal testing, vaccination, and tech-driven care.

中国启动了一项新的国家防治肝炎行动计划,旨在到2030年将5岁以下儿童乙型肝炎的流行率降低至0.2%,并将母婴传播限制在1%或以下。 China has launched a new national action plan to combat hepatitis, aiming to reduce hepatitis B prevalence in children under 5 to 0.2% by 2030 and limit mother-to-child transmission to 1% or less. 该计划强调保持儿童A型和B型肝炎95%以上的疫苗接种覆盖率,要求严格核查学校和儿童保育设施的免疫接种记录。 The plan emphasizes maintaining over 95% vaccination coverage for hepatitis A and B in children, requiring strict verification of immunization records in schools and childcare facilities. 它规定对孕妇普遍进行乙型肝炎检测,对受感染母亲的新生儿立即进行产后疫苗接种和免疫球蛋白,并扩大对高危成年人的疫苗接种。 It mandates universal hepatitis B testing for pregnant women, immediate post-birth vaccination and immunoglobulin for newborns of infected mothers, and expanded vaccination for high-risk adults. 到2030年,国家设定了慢性乙型肝炎80%的诊断和治疗率,利用技术改善病例检测和治疗,包括基于互联网的护理模式。 By 2030, the country targets 80% diagnosis and treatment rates for chronic hepatitis B, using technology to improve case detection and treatment access, including internet-based care models.